Tens of millions of UK-made coronavirus vaccines will be ready for production by the end of the year, claims a professor overseeing the trial.
Professor Andrew Pollard, chief investigator of the Oxford/AstraZeneca vaccine trial, was “optimistic” to get approval on the jab by Christmas.
His team's work was a “miracle” that was done at “record speed”, he said, adding that the vaccine is on the cusp of demonstrating “efficacy”.
It comes after New York-based pharmaceutical giant Pfizer gave the world fresh hope for a vaccine when it announced its experimental jab was more than 90 per cent effective in preventing the disease.